High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients

Jian Cong Sun,Xiao Ting Liang,Ke Pan,Hui Wang,Jing Jing Zhao,Jian Jun Li,Hai Qing Ma,Yi Bing Chen,Jian Chuan Xia

High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients

2010

Jian Cong Sun
Xiao Ting Liang
Ke Pan
Hui Wang
Jing Jing Zhao
Jian Jun Li
Hai Qing Ma
Yi Bing Chen
Jian Chuan Xia

CONCLUSION: High expression level of EDIL3 predicts poor prognosis of HCC patients. EDIL3 may be a potential target of antiangiogenic therapy for HCC.

Keywords:

Oncology
General surgery
Angiogenesis
Survival rate
Hepatocellular carcinoma
Immunohistochemistry
Pathology
Carrier protein
Diabetes mellitus
Medicine
Internal medicine
poor prognosis
antiangiogenic therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations